Revlon kicks off new philanthropic platform with $1M donation

Dr. Dennis J. Slamon, Revlon global brand ambassador Halle Berry and Revlon CEO Lorenzo Delpani at the Revlon Love is On Luncheon Honoring Slamon in Los Angeles (Photo: Business Wire)

NEW YORK — Revlon has donated $1 million to the Revlon/UCLA Women’s Cancer Research Program, furthering its long-time commitment to eradicating women’s cancers.



The donation was unveiled on June 3 by Revlon chairman Ronald Perelman, CEO Lorenzo Delpani and global brand ambassador Halle Berry at a Lovee Is On event in Los Angeles. The luncheon honored Dr. Dennis J. Slamon, director of the Revlon/UCLA Women’s Cancer Research Program at UCLA’s Jonsson Comprehensive Cancer Center, for his achievements in cancer research.



The donation marks the first phase of Revlon’s new philanthropic platform of bigger and more impactful donations to women’s health initiatives, which is also part of Revlon’s Love is On global mission to inspire love.



“Love Is On is in everything we do at Revlon, including our commitment to caring for women’s health,” Delpani said. “It is love that inspired our philanthropic direction to make more significant and impactful donations to women’s health initiatives. We unveiled the first phase of this mission with a direct donation of $1 million to Dr. Dennis Slamon and the Revlon/UCLA Women’s Cancer Research Program. It is our goal that this donation will help to enable Dr. Slamon and his team to continue their research into major cancer breakthroughs that will lead to lives being saved, ultimately finding a cure.”



“We have made tremendous advancements in the field of breast cancer treatments over the past two decades, but our work is far from over,” Slamon added. “We are currently working on potential new therapies and treatments for triple-negative breast cancer and ovarian cancer, and this extremely generous donation will help us to continue this groundbreaking research that has the potential to save the lives of more women battling these deadly diseases.”



Since 1990, Perelman and Revlon, in collaboration with the Entertainment Industry Foundation and Lilly Tartikoff, have distributed $49 million to the Revlon/UCLA Women’s Cancer Research Program. These funds have helped accelerate research needed to bring cancer treatment drugs such as Herceptin and Ibrance to market.

Revlon will be unveiling a new campaign later this year to raise awareness and funds in support of other women’s health initiatives.